R Squared’s Guardant Health GH Stock Holding History

R Squared’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-860	Closed	-$26.3K	–	758
2024 Q4	$26.3K	Buy	+860	New	+$24.2K	0.03%	758

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

R Squared's GH Position: Q1 2025 in Review

R Squared sold out of Guardant Health (GH) in Q1 2025, closing a stake of 860 shares — an estimated $26.3K sold.

R Squared first reported a position in GH in Q4 2024 and held it in 1 quarter. The position peaked at $26.3K in Q4 2024. 342 funds tracked by Wall St. Rank hold GH as of Q1 2025.

R Squared reported no remaining Guardant Health position as of Q1 2025 after selling out during the quarter.
R Squared sold 860 Guardant Health shares in Q1 2025, an estimated $26.3K.
R Squared first reported a position in Guardant Health in Q4 2024 and held it in 1 quarter.
R Squared's Guardant Health position peaked at $26.3K in Q4 2024.
342 funds tracked by Wall St. Rank held Guardant Health as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.